Adicet Bio, Inc.|4Sep 17, 9:50 PM ET

ABBOT STEWART 4

4 · Adicet Bio, Inc. · Filed Sep 17, 2020

Form 4

Period: 2020-09-15

See Remarks

Transactions

Award
Incentive Stock Option (right to buy)
2020-09-17+63,751→ 63,751 total
Exercise: $16.11Exp: 2030-09-17→ Common Stock (63,751 underlying)
Award
Employee Stock Option (right to buy)
2020-09-15+84,791→ 84,791 total
Exercise: $2.26Exp: 2028-08-14→ Common Stock (84,791 underlying)
Award
Employee Stock Option (right to buy)
2020-09-15+57,151→ 57,151 total
Exercise: $5.97Exp: 2029-10-15→ Common Stock (57,151 underlying)

Footnotes (5)

[F1]25% of the option vested on June 27, 2019, and 1/36th of the remaining unvested option vests on each of the next thirty-six (36) monthly anniversaries thereafter, provided that Dr. Abbot remains in continuous service as of the applicable vesting date.
[F2]Received in exchange for an employee stock option to acquire 683,800 shares of common stock of Adicet Bio, Inc., a Delaware corporation ("Old Adicet"), for $0.280 per share in connection with the merger (the "Merger") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation ("resTORbio"). On the effective date of the Merger, resTORbio changed its name to "Adicet Bio, Inc."
[F3]1/48th of the option vests on each of the forty-eight (48) monthly anniversaries of October 15, 2019, provided that Dr. Abbot remains in continuous service as of the applicable vesting date.
[F4]Received in exchange for an employee stock option to acquire 460,900 shares of common stock of Old Adicet for $0.740 per share in connection with the Merger.
[F5]1/48th of the shares of common stock subject to the option shall vest on each of the forty-eight (48) monthly anniversaries of the vesting commencement date, provided that Dr. Abbot remains in continuous service as of the applicable vesting date.

Documents

1 file